Tuberculosis (TB) is a leading cause of morbidity and mortality from a single infectious
agent, despite being preventable and curable. Early and accurate diagnosis of active TB is …

Rapid diagnosis is one key pillar to end tuberculosis (TB). Point-of-care tests (POCTs)
facilitate early detection, immediate treatment, and reduced transmission of TB disease. This …

Background Bringing reliable and accurate tuberculosis (TB) diagnosis closer to patients is
a key priority for global TB control. Molbio Diagnostics have developed the Truenat point-of …

ABSTRACT The Truenat MTB Plus assay is a rapid molecular test that has been
recommended by the World Health Organization since 2020 as an initial test to detect …

Background Decentralised molecular testing for tuberculosis could reduce missed
diagnoses and losses to follow-up in high-burden settings. The aim of this study was to …

Objective Point-of-care testing (POCT) has become an essential diagnostic technology for
optimal patient care. Its implementation, however, still falls behind. This paper reviews the …

BACKGROUND: Diagnostic delay and drug resistance not only worsen the outcomes of
tuberculous meningitis (TBM), but are also important impediments to TB elimination efforts …

Background Despite expanded access to antiretroviral therapy (ART) and the rollout of the
World Health Organization's (WHO)'test‐and‐treat'strategy, the proportion of people with HIV …

Rapid, cost-effective, and sensitive diagnostic assays are essential for global tuberculosis
(TB) control, especially in high TB burden, resource-limited settings. The current study was …

Current strategies to promptly, effectively, and equitably screen people with tuberculosis
(TB) and link them to diagnosis and care are insufficient; new approaches are required to …